RecruitingNot ApplicableNCT03135327

Clinical Applications of Advanced Ophthalmic Imaging


Sponsor

University of Miami

Enrollment

5,000 participants

Start Date

Jan 1, 2007

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to determine the clinical application of advanced ophthalmic imaging devices such as optical coherence tomography (OCT), retinal function imager (RFI), slit-lamp biomicroscopy (SLB), PERG in diseased eyes and normal controls. There are two phases in this study. The first phase is an observational phase which studies the eye in various conditions. The second phase is an interventional phase which studies the changes in the eyes after taking an over-the-counter medical food (Ocufolin) for 6 months.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This trial uses advanced eye imaging technology to study connections between eye health and brain conditions like Alzheimer's disease, multiple sclerosis, diabetes, and stroke. **You may be eligible if...** - You are a healthy volunteer, OR you have been diagnosed with Alzheimer's disease, mild cognitive impairment, multiple sclerosis, dry eye, myopia, diabetes, or stroke - You can keep your eye open for imaging - For the interventional phase: you are at least 18 years old, have clear eye lenses, vision of 20/80 or better, and meet specific genetic and blood test criteria **You may NOT be eligible if...** - You cannot read and sign the consent form - You cannot receive ophthalmic imaging or tolerate bright light - For the interventional phase: you have an active eye disease or had eye surgery or injury within the past 6 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTOcufolin

Ocufolin medical food capsules will be taken once a day by mouth each morning with a meal for the first week, two capsules orally each morning with a meal for the second week and three capsules orally each morning with a meal for the rest of the 6 months study duration.


Locations(1)

Bascom Palmer Eye Institute

Miami, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03135327


Related Trials